145 related articles for article (PubMed ID: 17005002)
1. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation.
Smith EL; Finney HM; Nesbitt AM; Ramsdell F; Robinson MK
Immunology; 2006 Oct; 119(2):203-11. PubMed ID: 17005002
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
[TBL] [Abstract][Full Text] [Related]
3. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
6. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
Carson BD; Ziegler SF
Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
10. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.
Merlo A; Tagliabue E; Mènard S; Balsari A
Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349
[TBL] [Abstract][Full Text] [Related]
11. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
12. Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis.
Ryder LR; Woetmann A; Madsen HO; Ødum N; Ryder LP; Bliddal H; Danneskiold-Samsøe B; Ribel-Madsen S; Bartels EM
Scand J Rheumatol; 2010 Aug; 39(4):279-86. PubMed ID: 20476861
[TBL] [Abstract][Full Text] [Related]
13. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.
Saruta M; Yu QT; Fleshner PR; Mantel PY; Schmidt-Weber CB; Banham AH; Papadakis KA
Clin Immunol; 2007 Dec; 125(3):281-90. PubMed ID: 17897887
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
[TBL] [Abstract][Full Text] [Related]
15. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions.
Okui T; Ito H; Honda T; Amanuma R; Yoshie H; Yamazaki K
Oral Microbiol Immunol; 2008 Feb; 23(1):49-54. PubMed ID: 18173798
[TBL] [Abstract][Full Text] [Related]
17. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
18. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
Campbell DJ; Ziegler SF
Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
[TBL] [Abstract][Full Text] [Related]
19. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
20. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene.
Torgerson TR; Linane A; Moes N; Anover S; Mateo V; Rieux-Laucat F; Hermine O; Vijay S; Gambineri E; Cerf-Bensussan N; Fischer A; Ochs HD; Goulet O; Ruemmele FM
Gastroenterology; 2007 May; 132(5):1705-17. PubMed ID: 17484868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
